HPSE and gastric cancer: Inhibition of heparanase by heparin/HS mimicking compounds, neutralizing antibodies and/or small molecules may block this self-sustaining pro-inflammatory cycle and thereby reduce the risk of gastritis and the associated gastric cancer.